Allogene Therapeutics
Angelica Sandoval is an experienced professional in clinical operations and logistics management, currently serving as Senior Manager of Clinical Operations at Allogene Therapeutics since October 2023. Previously, Angelica held the position of Logistics Senior Manager and Head of Trade Compliance at Turnstone Biologics from April 2023 to October 2023. Prior roles include Clinical Logistics TIL Lead and Clinical Trial Management Associate at Instil Bio, Logistics Manager at Poseida Therapeutics, and Clinical Logistics Coordinator at Kite Pharma. Earlier in her career, Angelica worked as a Senior Site Coordinator and Site Coordinator at PerkinElmer, Inc. Angelica earned a Bachelor of Arts degree in Biology from Mount Saint Mary's University between 2014 and 2017.
This person is not in any teams
This person is not in any offices
Allogene Therapeutics
1 followers
Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. The goal of our allogeneic cell therapy platform is simple: take the same biological processes that allow the first generation autologous CAR T therapies to deliver breakthrough clinical benefits but eliminate the need to create a personalized therapy for each patient. Instead, we start with T cells from healthy donors, which is intended to allow for creation of inventory for “off-the-shelf” use in patients faster, more reliably, and at greater scale.